Of everything people worry about with GLP-1 injections, this is the one that comes up most: am I losing muscle instead of fat?
It’s a fair thing to worry about. Muscle underpins strength, mobility, blood sugar control and (further down the line) whether you can live independently. If appetite drops off a cliff and someone is suddenly eating far less than before after taking GLP-1, asking what the body is drawing on is a sensible question, not a paranoid one.
The short version: yes, some lean mass usually goes when you take GLP-1. That’s true of weight loss generally, whether it comes from dieting, surgery or medication. What it isn’t is evidence that these drugs attack muscle, and it isn’t a reason to assume every kilogram labelled “lean mass” on a scan was skeletal muscle.
The research on GLP-1 over the last couple of years has actually been reassuring. It’s also made the picture more complicated than either side of the argument tends to admit. Here’s what’s known, and what anyone on weight-loss treatment can do about it.
1. This isn’t a GLP-1 problem, it’s a weight loss problem
Lose a meaningful amount of weight and almost none of it comes purely from fat. A smaller body needs less supporting tissue, and eating less means the body draws on both fat and lean tissue for energy.
That’s true of calorie restriction. True of bariatric surgery. True of GLP-1.
So “was any lean mass lost?” isn’t a useful question, because the answer is nearly always yes. The useful questions are whether the amount was disproportionate, whether real skeletal muscle was affected, and whether the person actually became weaker.
A 2025 body-composition analysis from a major weight-loss trial found that about 74% of the weight lost on a dual pathway weekly injection came from fat and 26% from lean mass. The comparison group split much the same way, which is the detail that matters. If the drug were uniquely muscle wasting, you’d expect the ratio to look worse than ordinary weight loss. It didn’t.
That doesn’t make lean mass loss unimportant. It makes it something to interpret rather than panic about.
2. “Lean mass” is not a synonym for muscle
This gets missed constantly, and almost every alarming headline on this subject depends on missing it.
Body composition scans sort you into three buckets: fat, bone, and lean mass. That third one is simply everything else skeletal muscle, yes, but also organs, connective tissue, body water, and glycogen along with the water stored alongside it.
So a scan reporting three kilograms of lean mass lost has not established that three kilograms of muscle vanished. Shifts in hydration and glycogen move that number around. Weight loss also shrinks organs, or reduces the fat inside them, the liver in particular.
A 2026 study in Cell Reports Medicine found that in its animal work, the drop in liver mass exceeded the change in muscle mass. Its human proof of concept arm went further and measured muscle size and strength directly, rather than trusting the lean-mass category to stand in for muscle.
Which is the point. A body composition printout is not a muscle measurement, and treating it as one produces a lot of unnecessary alarm.
3. Most of what comes off is fat
The body composition studies do show absolute lean mass falling. They also consistently show fat falling further on GLP-1.
In the 2025 analysis above, roughly three quarters of the loss was fat. An exploratory analysis from another major GLP-1 trial found the same direction of travel, total fat and visceral fat both fell more than lean mass did, so that by the end, lean tissue made up a larger proportion of a considerably lighter body.
That distinction is worth sitting with, because it’s counterintuitive. You can finish treatment with slightly less absolute muscle and a healthier ratio of muscle to bodyweight than you had before. And carrying less excess weight makes stairs, walking and exercise easier, which tends to feed back into doing more of them.
The goal of GLP-1 was never “lose zero lean tissue.” It’s maximise fat loss, hold onto useful muscle, and come out at least as functional as you went in.
4. Smaller muscle isn’t automatically weaker muscle
Size matters. It just isn’t the only thing that matters, and for daily life it may not be the thing that matters most.
The 2026 Cell Reports Medicine study found a small reduction in absolute muscle size in participants on a GLP-1 medicine, but maximum knee extension and hand grip strength didn’t significantly worsen. Body composition improved without measurable strength loss over the 12 weeks.
Read that carefully, though. Small trial, short duration, explicitly designed as early proof of concept. It doesn’t settle anything for older adults or people who are already frail, and larger, longer studies on GLP-1 are still needed before anyone gets confident.
What it does undercut is the assumption that any drop in lean mass must translate into weakness. Someone can get lighter, lose a little absolute muscle, and move as well as they did before or better.
5. The risk isn’t evenly distributed
Trial averages flatten out enormous individual variation. A 45 year old who lifts twice a week and eats properly is in a completely different position from a 78 year old who is already frail and eating very little.
Muscle preservation deserves more deliberate attention in anyone who:
- Is older, or already has low muscle mass
- Has limited mobility, or spends most of the day sitting
- Is losing weight very fast
- Is struggling to eat because of nausea, vomiting or heavily suppressed appetite
- Routinely eats very little protein, or very few calories overall
- Has a chronic illness affecting nutrition, strength or mobility
- Has recently been unwell, hospitalised, or off their feet for a while
None of these rules anyone out of GLP-1 treatment. They change the emphasis, more attention on protein and function and often a deliberately slower rate of loss.
And the scale won’t tell you any of this. It cannot distinguish someone getting healthier from someone quietly getting weaker.
6. Protein helps. Protein alone doesn’t.
GLP-1 makes eating less very easy. For some people it goes further than intended, and the appetite suppression pushes out nutritious food alongside the excess.
Protein supplies the amino acids used to maintain and repair muscle. When portions shrink, the practical move is giving protein a fixed place in the meal rather than treating it as the thing you get to if you’re still hungry which, on these drugs, you usually aren’t.
Reasonable sources:
- Eggs, fish, chicken, lean meat
- Greek yoghurt, milk, cottage cheese
- Tofu, tempeh, soy milk
- Beans, lentils and other pulses
- A protein supplement, when eating normally is genuinely difficult
There’s no universal target for GLP-1 weight loss. Requirements shift with body size, age, activity, health conditions and kidney function and anyone with kidney disease or other dietary restrictions should get individual advice before substantially increasing intake.
The bigger point: protein without loading the muscles is half a strategy. A 2025 joint clinical advisory on nutrition during GLP-1 treatment stressed both adequate protein and structured strength work. Eating more protein while sedentary doesn’t give the body a reason to keep the muscle.
7. Resistance training is the strongest lever you have
Muscle responds to demand. Ask it regularly to lift, push, pull or hold the body against resistance, and it has a reason to stay. Stop asking, and it doesn’t.
This does not mean a bodybuilding programme. Depending on where you’re starting:
- Sitting down to a chair and standing back up
- Push ups against a wall or kitchen counter
- Resistance bands
- Light dumbbells
- Step ups
- Gym machines
- Supervised strength or rehab work
Train the major muscle groups regularly, and make it slightly harder as it gets easier. That progression is the part people skip, and it’s the part that does the work.
Walking is excellent for cardiovascular health, mood and general activity. It is not a substitute here. It doesn’t provide the stimulus that keeps muscle.
If you’ve been inactive, have joint problems, feel unsteady on your feet, or have a heart condition or other significant health issue, get guidance before starting anything demanding. A few controlled movements done properly beats an intense routine copied off social media, which is how people end up injured in week two and stop entirely.
How would you know if you were losing too much?
A body composition scan gives useful information. It isn’t the only signal, and it isn’t the most practical one.
Watch what your body actually does:
- Can you get out of a chair as easily as before?
- Can you carry the shopping the way you used to?
- Stairs? Any new difficulty?
- Has your usual walking pace changed?
- Does your normal workout feel harder at the same weights?
- Are you recovering from activity the way you did?
Get medical advice for persistent weakness, falls, trouble with ordinary tasks, dizziness, severe fatigue, or an inability to eat enough. Ongoing vomiting or diarrhoea needs attention too as dehydration affects both how you feel and what a body-composition scan reports.
Protecting strength while you lose weight
Worth building the GLP-1 plan around these rather than the scale:
- Protein in every meal, not just the ones you feel like eating
- Resistance training consistently, not occasionally
- Movement through the day, beyond the training itself
- Enough fluid, especially with gastrointestinal side effects
- Never increasing your own dose
- Raising persistent appetite loss or side effects with your doctor rather than just eating less and less
- Tracking strength, mobility and energy alongside weight
- Habits that will survive past the weight loss phase, because that’s when they matter most
The best plan usually isn’t the one producing the fastest weekly drop. Slower loss that protects nutrition, strength and function tends to produce a better result and a more durable one.
The bottom line
The muscle concern is real. The alarming version of it isn’t well supported.
Weight loss does include some lean tissue. But lean mass isn’t the same as skeletal muscle, and the major studies consistently show most of what comes off is fat. The newer evidence suggests GLP-1 medicines don’t cause disproportionate or automatically harmful muscle loss in the middle-aged adults studied so far while leaving genuinely open what happens in older, frailer, inactive or poorly nourished people, who need closer attention.
Nutrition and resistance training remain the two things that actually protect strength during weight loss with GLP-1. They’re unglamorous, they’re within your control, and nothing else comes close.
MedConsult Clinic can review your weight-loss progress, side effects, eating pattern and changes in strength to help decide whether your current approach still suits you.
This article provides general health information and does not replace an individual medical assessment.